Home › Eierstokkanker › Californië › Baldwin Park
Eierstokkanker klinische studies in Baldwin Park, CA
25 studies voor Eierstokkanker zoeken deelnemers op locaties in en rond Baldwin Park (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RekruterenFase 1/2
- Research Site, Duarte · 4 mijl verwijderd
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruterenFase 1
- City of Hope National Medical Center, Duarte · 4 mijl verwijderd
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruterenFase 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mijl verwijderd
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruterenFase 2
- City of Hope, Duarte · 4 mijl verwijderd
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
RekruterenFase 1
- City of Hope National Medical Center /ID# 281381, Duarte · 4 mijl verwijderd
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RekruterenFase 1
- Research Site, Duarte · 4 mijl verwijderd
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
RekruterenFase 1/2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mijl verwijderd
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruterenFase 3
- City of Hope, Duarte, Duarte · 4 mijl verwijderd
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruterenFase 1
- City of Hope Cancer Center, Duarte · 4 mijl verwijderd
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
RekruterenFase 1/2
- City of Hope National Medical Center, Duarte · 4 mijl verwijderd
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruterenFase 1/2
- City of Hope, Duarte · 4 mijl verwijderd
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekruterenFase 3
- City of Hope Medical Center, Duarte · 4 mijl verwijderd
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruterenFase 1
- City of Hope, Duarte · 4 mijl verwijderd
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
RekruterenFase 3
- City of Hope, Duarte · 4 mijl verwijderd
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
RekruterenFase 1
- City of Hope Medical Center, Duarte · 4 mijl verwijderd
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RekruterenFase 1
- City of Hope, Duarte · 4 mijl verwijderd
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Rekruteren
- City of Hope Medical Center, Duarte · 4 mijl verwijderd
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekruteren
- City of Hope Comprehensive Cancer Center, Duarte · 4 mijl verwijderd
AOH1996 for the Treatment of Refractory Solid Tumors
RekruterenFase 1
- City of Hope Medical Center, Duarte · 4 mijl verwijderd
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekruteren
- Beckman Research Institute of City of Hope, Duarte · 4 mijl verwijderd
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RekruterenFase 3
- City of Hope, Duarte · 4 mijl verwijderd
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
RekruterenFase 1
- City of Hope, Duarte · 4 mijl verwijderd
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- City of Hope, Duarte · 4 mijl verwijderd
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
RekruterenFase 2
- City of Hope National Medical Center, Duarte · 4 mijl verwijderd
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Duarte · 4 mijl verwijderd
Eierstokkanker studies in andere steden
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Andere studies in Baldwin Park
- Borstkanker44 studies
- Acute myeloïde leukemie40 studies
- Colorectale kanker37 studies
- Niet-kleincellige longkanker36 studies
- Kanker (alle vormen)34 studies
- Prostaatkanker30 studies
- Metastatische kanker30 studies
- Myelodysplastische syndromen26 studies
- Longkanker24 studies
- Multipel myeloom23 studies
- Maagkanker22 studies
- Acute lymfoblastaire leukemie21 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.